Your browser doesn't support javascript.
loading
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy.
Perry, Briana N; Vais, Simone; Boateng, Jeffery O; Jain, Mayuri; Wachman, Elisha M; Saia, Kelley A.
Affiliation
  • Perry BN; From the Department of Obstetrics and Gynecology, Boston Medical Center, Boston, MA (BNP, KAS); Boston University School of Medicine, Boston, MA (SV, EMW, KAS); Boston University School of Public Health, Boston, MA (JOB, MJ); and Department of Pediatrics, Boston Medical Center, Boston, MA (EMW).
J Addict Med ; 16(6): e399-e404, 2022.
Article in En | MEDLINE | ID: mdl-35916423
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: J Addict Med Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: J Addict Med Year: 2022 Document type: Article Country of publication: